4-[[(4-Fluorophenyl)imino]methyl]-phenol CAS 3382-63-6 Ezetimibe Pakati Pekuchena ≥99.0% Factory
Manufacturer Supply;High Quality uye Competitive Price
Commercial Supply Ezetimibe (CAS: 163222-33-1) Related Intermediates:
(S)-(+)-4-Phenyl-2-oxazolidinone CAS: 99395-88-7
(R)-(+)-2-Methyl-CBS-oxazaborolidine CAS: 112022-83-0
4-(4-Fluorobenzoyl) butyric acid CAS: 149437-76-3
4-[[(4-Fluorophenyl)imino]methyl]-phenol CAS: 3382-63-6
N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline CAS: 70627-52-0
(3R,4S) -4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3--[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-imwe CAS: 190595-65 -4
(4S)-3- [5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone CAS: 189028-93-1
(4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-imwe CAS: 189028-95-3
Ezetimibe CAS: 163222-33-1
Chemical Name | 4-[[(4-Fluorophenyl)imino]methyl]-phenol |
Nhamba yeCAS | 3382-63-6 |
Nhamba yeCAT | RF-PI145 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C13H10FNO |
Molecular Weight | 215.22 |
Melting Point | 179.0 kusvika 183.0 ℃ |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Kubva-Kuchena kusvika kuUpfu Huchena |
Kuchena / Analysis Method | ≥99.0% (HPLC) |
Kurasika paKuomesa | ≤0.50% |
Kusachena Kumwechete | ≤0.50% |
Zvose Zvisina Kuchena | ≤1.0% |
Heavy Metals | ≤20ppm |
Test Standard | Enterprise Standard |
Usage | Ezetimibe (CAS: 163222-33-1) Pakati |
Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.
Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi we4-[[(4-Fluorophenyl)imino]methyl]-phenol (CAS: 3382-63-6) ine mhando yepamusoro, iri pakati peEzetimibe ( CAS: 163222-33-1).Ezetimibe is anti-hyperlipidemic drug inoshandiswa kuderedza mazinga eplasma cholesterol.Ezetimibe inonzi cholesterol transport inhibitor inosunga kuNPC1L1.Iyo inoratidzwa seadjunctive therapy kune kudya kwekuderedzwa kwepamusoro-level yakazara-C, LDL-C, uye ApoB kune varwere vanotambura chekutanga (heterozygous mhuri uye isiri yemhuri) hypercholesterolemia.